Dr. Schwartz is responsible for managing the scientific conduct of clinical trials sponsored by CONRAD including site evaluation and selection, protocol development and implementation, study safety monitoring, and writing the final report and manuscript. She is also an assistant professor in the Department of Obstetrics and Gynecology at EVMS. Dr. Schwartz received her B.A. degree in Psychology from Wesleyan University in 1985. After completing her medical degree from Mount Sinai School of Medicine in 1991, she continued her medical training in Obstetrics and Gynecology with an internship at the Long Island Jewish Medical Center. Dr. Schwartz worked at Planned Parenthood NYC from 1992 to 1994 as a staff physician and then completed a residency in Obstetrics and Gynecology at George Washington University Medical Center in 1997. She completed a fellowship in contraceptive research and family planning at Magee-Womens Hospital in 1999. In June 1999, she served as a consultant to Ipas (a non-profit agency) and the Ministry of Health in Vietnam, training physicians in surgical procedures at Benh Vieu Phu San Hospital in Hanoi, and conducting reproductive health updates in Soc Trang and An Giang. Prior to joining CONRAD in 2002, she served as Assistant Professor, Director of the Emergency Department, and Assistant Director of Ambulatory Services in the Department of Obstetrics, Gynecology, and Reproductive Sciences at the University of Pittsburgh School of Medicine. Dr. Schwartz has co-authored several papers, including a recent review with Dr. Gabelnick on contraceptive research, which appears in the November/December 2002 issue of Perspectives on Sexual and Reproductive Health.
- Contraceptive Efficacy, Safety, Fit, and Acceptability of a Single-Size Diaphragm Developed With End-User Input.
- Comparison of Visual and Ultraviolet Light Inspection Versus DNA/Protein Biomarkers to Assess Product Adherence With Vaginal Microbicide Applicators
- Effect of lubricants and a vaginal spermicide gel on the detection of prostate specific antigen, a biomarker of semen exposure, using a quantitative (Abbott ARCHITECT) assay.
- Clinical Safety and Pharmacology Trial
- Toward early safety alert endpoints: exploring biomarkers suggestive of microbicide failure
- A randomized, comparative safety study of a prefilled plastic and user-filled paper applicator with candidate microbicide tenofovir 1% gel
- Medroxyprogesterone acetate and estradiol cypionate injectable suspension (Cyclofem) monthly contraceptive injection: steady-state pharmacokinetics
- Dyeing to know: the use of vaginal applicator staining and other techniques to assess adherence to product use in microbicide trials
- Colposcopy: still useful in microbicide safety trials?
- A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gel
- Baseline variation and associations between subject characteristics and five cytokine biomarkers of vaginal safety among healthy non-pregnant women in microbicide trials
- Reddy female condom: functional performance of a 90-mm shaft length in two clinical studies
- Baseline factors associated with incident HIV and STI in four microbicide trials
- Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception
- Safety evaluation of 1% tenofovir gel in healthy men
- Critical next steps for female condom research: report from a workshop
- Comparative crossover study of the PATH Woman's Condom and the FC Female Condom®
- Six-day randomized safety trial of intravaginal lime juice
- SILCS diaphragm: postcoital testing of a new single-size contraceptive device
- A randomized six-day safety study of an antiretroviral microbicide candidate UC781, a non-nucleoside reverse transcriptase inhibitor
- Noncomparative contraceptive efficacy of cellulose sulfate gel
- Fourteen-day safety and acceptability study of the universal placebo gel